Ameriprise
CBIO

Ameriprise’s Crescent Biopharma CBIO Stock Holding History

Ameriprise’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-163
Closed -$61K – 3858
2020
Q4 		$61K Sell
163
-78
-32% -$27.3K ﹤0.01% 3715
2020
Q3 		$74K Buy
241
+31
+15% +$11.8K ﹤0.01% 3661
2020
Q2 		$79K Buy
+210
New +$59.5K ﹤0.01% 3596
2018
Q1 		– Sell
-977
Closed -$1.64M – 3647
2017
Q4 		$1.64M Buy
977
+2
+0.2% +$2.65K ﹤0.01% 2756
2017
Q3 		$1.36M Buy
975
+12
+1% +$14.1K ﹤0.01% 2818
2017
Q2 		$1.07M Buy
+963
New +$796K ﹤0.01% 2914

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return